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The effect of acanthoic acid analogs on the response
to proinflammatory challenge was investigated.
Some pimarane diterpenes are known activators of
the LXRab nuclear receptors, but we show here
that they also exert a rapid, potent, and selective
activation of the p110g and p110d subunits of PI3K.
Combination of these effects results in an important
attenuation of the global transcriptional response to
LPS in macrophages. PI3K/Akt activation leads to
inhibition of the LPS-dependent stimulation of IKK/
NF-kB and p38 and ERK MAPKs. Macrophages
from LXRab-deficient mice exhibited an inhibition
of these pathways similar to the corresponding
wild-type cells. Silencing or inhibition of p110g/d
suppressed the effect of these diterpenes (DTPs)
on IKK/NF-kB andMAPKs signaling. Taken together,
these data show a multitarget anti-inflammatory
mechanism by these DTPs including a selective acti-
vation of PI3K isoenzymes.
INTRODUCTION
Macrophages are key players in the innate immune response
(Gordon, 2007). During the inflammatory process, the early
stages are dominated by macrophages displaying inflammatory
and tissue-destructive activities followed by tissue repair (Gor-
don and Martinez, 2010; Mantovani et al., 2004). To carry out
these functions, macrophages have membrane receptors,
which recognize antigens (such as Toll-like receptor [TLR] li-
gands or pathogen-associated molecular patterns); cytokines;
and chemokines, which trigger the specificity of the innate im-
mune response (Garantziotis et al., 2008; Nathan and Ding,
2010; Pasare and Medzhitov, 2004). TLRs exert essential func-Chemistry & Biology 21, 95tions in the activation of innate immunity as sensors of microbi-
al infection (Garantziotis et al., 2008; Trinchieri and Sher, 2007),
leading to the killing and clearance of pathogens. Signaling
downstream from TLRs involves the recruitment of distinct
Toll/interleukin-1 receptor (TIR)-domain-containing adaptor
molecules including the myeloid differentiation factor 88
(MyD88) and the TIR-domain-containing adaptor-inducing
interferon b (IFNb) (TRIF) (Akira and Takeda, 2004; Jin and
Lee, 2008; Kawai and Akira, 2011; Kumar et al., 2009; O’Neill
and Bowie, 2007). Most TLRs signal through MyD88-depen-
dent pathway, whereas TLR3, the receptor recognizing dou-
ble-stranded RNA (dsRNA), is coupled to TRIF. TLR4, the re-
ceptor for lipopolysaccharide (LPS), is the only receptor that
engages both MyD88- and TRIF-dependent pathways.
MyD88- and TRIF-dependent pathways result in the activation
of the transcription factor nuclear factor kappa B (NF-kB). TLRs
also activate phosphatidylinositol 3-kinase (PI3K)/Akt pathway,
which plays an important role in cell migration, phagocytosis,
and apoptosis (Dı´az-Guerra et al., 1999; Fukao and Koyasu,
2003; Katso et al., 2001; Troutman et al., 2012) and regulates
MyD88- and TRIF-dependent events (Arbibe et al., 2000; Ha-
zeki et al., 2007; Sarkar et al., 2004). PI3K converts phosphati-
dylinositol 4,5-bisphosphate (PIP2) into phosphatidylinositol
(3,4,5)-trisphosphate, which acts as second messenger to acti-
vate downstream protein kinases, including Akt (Franke et al.,
1995; Guha and Mackman, 2002). Indeed, PI3K activation in
macrophages contributes to the negative regulation of the
NF-kB pathway, decreasing the inflammatory response (Aksoy
et al., 2005, 2012; Chaurasia et al., 2010; Dı´az-Guerra et al.,
1999; Guha and Mackman, 2002; Medina et al., 2010; van
Dop et al., 2010).
The ability of natural and chemically modified diterpenes
(DTPs) and polyphenols to impair inflammatory responses
has been evaluated in the past years (Bremner and Heinrich,
2002; de las Heras et al., 2003; Palladino et al., 2003). Most
of the studies on terpenes have focused on NF-kB pathway
as a common target in the action of these compounds,
explaining their anti-inflammatory and immunomodulatory5–966, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 955
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targets have been identified in this pathway, ranging from
the inhibition of upstream kinases, NF-kB-inducing kinase
and IkB kinase (IKK), and p65 phosphorylation, to the upregu-
lation of the inhibitory proteins IkBa and Bcl-3. Some DTPs
also activate nuclear receptors, such as liver X receptors
(LXRs), contributing in this way to antagonize NF-kB activa-
tion by ligand-dependent transrepression (Castrillo et al.,
2001a; de las Heras et al., 1999, 2003, 2007; Jayasuriya
et al., 2005; Traves et al., 2007). Acanthoic acid exhibits
in vivo anti-inflammatory activity inhibiting tumor necrosis fac-
tor a (TNF-a) production and exerting antifibrotic effects in
models of experimental silicosis (Kang et al., 1996) and pro-
tective effects against fulminant hepatic failure in mice (Nan
et al., 2008).
In this work, we have investigated the effect on macrophage
activation and systemic inflammation of DTPs structurally
related to acanthoic acid, with different substitutions at the car-
bon 4 position of ring A (Figure 1A). Previous studies showed
that these DTPs activated LXRab and inhibited TNF-a release
without noticeable effects on apoptosis in normal lymphoid cells
(Chao et al., 2005; Traves et al., 2007). Our data extend these re-
ports and show that DTPs exert a potent and selective activation
of the p110g and p110d PI3K isoenzymes in macrophages.
Moreover, the inhibition or silencing of these isoenzymes impairs
the anti-inflammatory effects of DTPs on the early events of the
IKK/NF-kB pathway and on the p38 and extracellular signal
regulated-kinase (ERK) mitogen-activated protein kinase
(MAPKs), even in the absence of LXRab. Oral or systemic
administration of these DTPs confirmed the potential therapeu-
tic role and safe profile of these molecules as anti-inflammatory
drugs.
RESULTS
Acanthoic Acid-Related DTPs Inhibit the Expression of
Genes Mediating Inflammation in Peritoneal
Macrophages
The effect of DTP1, one of the five acanthoic acid C-4 deriva-
tives assayed in this work (Figure 1A), on LPS transcriptional
response in macrophages was analyzed. The profound impact
of LPS on macrophage gene expression has been well charac-
terized and even modeled by systems biology approaches
(Tegne´r et al., 2006). Accordingly, we identified a high numberFigure 1. Effect of Acanthoic Acid-Related DTPs on Inflammatory-Med
(A) Chemical structure of the five acanthoic acid C4 derivatives that were synthe
(B) Transcriptional response to LPS and DTP1 + LPS measured by gene express
the vehicle (DMSO) and then activated with 250 ng/ml of LPS for 4 hr. The numbe
number of DEGs after LPS + vehicle (left). The global fold changes (indicated in t
affected (right).
(C) Functional analysis of KEGG pathways using FatiScan resulted in 13 signific
upregulated (red) and the other ten were enriched in genes downregulated (blue
(D–F) After 18 hr of incubation, the protein levels of NOS-2 and COX-2 (D) and the
were incubated with staurosporine (200 ng/ml) or DTPs (10 mM) for 18 hr. Apopt
(G and H) Accumulation (after 18 hr) in the culture medium of IL-1b, CXCL-1 (KC
levels of IL-1b, CXCL-1, and CXCL-10 were also determined at 18 hr (H).
Results show a representative blot out of three (D and H) and the mean ± SD (n =
versus the LPS condition (G).
Chemistry & Biology 21, 95of differentially expressed genes (DEGs; 5,075 genes, false
discovery rate [FDR] % 0.05) between control and LPS-stimu-
lated cells (Figure 1B). Cotreatment with DTP1 and LPS re-
sulted in 50% reduction of DEGs (2,456 genes, using the
same FDR threshold), indicating that DTP1 partially inactivates
the transcription induced by LPS. Not only were fewer DEGs
observed after DTP1 treatment but also attenuation of the
LPS response was observed (Figure 1B, right). Functional
enrichment of the Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways analysis using FatiScan (Al-Shahrour et al.,
2006) are shown in Figure 1C. Most of the pathways that
were enriched in DTP1 downregulated genes were directly
related with inflammation and immunity, such as the leukocyte
migration, cytokine-receptor interaction, and TLR pathway.
Given the key role of the TLR pathway in the macrophage-
mediated inflammatory response, we characterized the genes
belonging to this signaling cascade in more detail. The relative
expression levels of the TLR pathway genes of macrophages
treated with LPS and LPS + DTP1 are shown in Figure S1A
(available online). Quantitative PCR (qPCR) analysis of selected
genes of this pathway confirmed these trends and showed
similar results between the DTP1 and DTP5 treatments (Fig-
ure S1B). Because DTP1 transrepresses a high number of
inflammation-related genes, this effect was compared to that
described for anti-inflammatory ligands that activated gluco-
corticoid receptor (GR), LXR, and peroxisome proliferator-
activated receptor gamma (PPARg) using published gene
sets (Ogawa et al., 2005). This resulted in the target genes of
the activated nuclear receptors (LXR, PPARg, and GR) being
significantly enriched in the panel of DTP1 downregulated
genes (Figure S2); moreover, the DTP1 transrepression profile,
in addition to overlapping with that of activated LXR
(GW3965), also transrepressed LPS-induced genes that are
LXR independent (those genes repressed exclusively by the
GR ligand dexamethasone and the PPARg ligand rosiglitazone,
but not by GW3965). This implies that DTP1 represses the in-
flammatory response by LXR-dependent and -independent
mechanisms.
We next designed a set of experiments to confirm the
decreased transcriptional response to LPS induced by DTPs.
Cells were incubated with DTPs and activated with LPS; then
the expression of nitric oxide synthase-2 (NOS-2) and cyclooxy-
genase-2 (COX-2) (Figure 1D) and the accumulation of nitrate
plus nitrite (NOx) in the culture medium were measurediators Expression
sized.
ion microarrays. Peritoneal macrophages were pretreated with 10 mM DTP1 or
r of significant DEGs (FDR% 0.05) obtained after DTP1 + LPS is about half the
he heat map as log2) of LPS up- and downregulated genes were dramatically
antly enriched (FDR % 0.05) pathways: three of them were enriched in genes
) by DTP1.
accumulation of NOx in the culture medium (E) were determined. Macrophages
osis was determined using flow cytometry using annexin-V labeling (F).
), CXCL-10 (IP-10), IFN-g, IL-6, RANTES, IL-10, and IL-12 (G). The intracellular
4; E–G). *p < 0.05, **p < 0.005 versus the vehicle condition (E and F); *p < 0.05
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Figure 2. DTP1 and DTP5 Inhibit TPA-
Induced Ear Edema and Delay LPS/D-GalN
Lethality
(A) Male C57BL/6 mice received topically the
indicated DTPs (0.5 mg in 20 ml DMSO) or indo-
methacin (0.5 mg in 20 ml) and TPA (2 mg in 20 ml).
After 1 hr, animals were sacrificed and the MPO
activity and the weight of identical sections of ear
tissues were determined.
(B) Pooled whole-blood samples from C57BL/6J
mice treated orally for 90 min with 25 mg/kg DTP1,
DTP2, and DTP5 prepared in 40% Solutol HS15
(vehicle) were stimulated ex vivo with LPS at
10 ng/ml and 100 ng/ml for 4 hr, and the TNF-a
levels were measured using ELISA.
(C) LXRab+/+ and LXRab/mice were injected i.p.
with 30 mg/kg body weight of the indicated DTPs
and 1 hr later were i.p. conditioned with LPS/
D-GalN. Results show the Kaplan-Meier repre-
sentation of the survival time of the groups (n = 10).
(D) Similarly, LXRab+/+ animals received i.p. the
indicated concentrations of DTP1 and DTP5, fol-
lowed 1 hr later by i.p. administration of LPS. The
TNF-a plasma levels were measured at 1 hr after
the LPS challenge.
(E) The in vivo effect of DTP5 (30 mg/kg; 1 hr prior
to administration of 10 mg/kg zymosan) on MPO
activity was measured in the whole animal by
quantifying the bioluminescence after challenge
with luminol (5 mg in 200 ml) using an IVIS-Lumina.
Results show the mean ± SD (n = 5; A, B, D, and E).
*p < 0.05, **p < 0.01 versus the corresponding
control.
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than 60% at 10 mM. To ensure that the inhibitory effects of these
compounds were not due to cytotoxicity, we analyzed the per-
centage of apoptotic cells using staurosporine as positive con-
trol (Figure 1F). In agreement with the anti-inflammatory activity
of DTP1 and DTP5, the accumulation in the culture medium of
IL-1b, chemokine (C-X-C motif) ligand 1 (CXCL-1), CXCL-10,
interferon g (IFNg), IL-6, chemokine ligand 5 (CCL5 or RANTES),
IL-12, and the anti-inflammatory cytokine IL-10 were decreased
in the presence of the DTPs (Figure 1G). The intracellular protein
levels of some of these cytokines and chemokines were
measured at 18 hr after LPS stimulation (Figure 1H).
DTP1 and DTP5 Exert In Vivo Anti-inflammatory Activity
The anti-inflammatory action of DTP1,DTP2, andDTP5was eval-
uated in a murine ear edema model. As Figure 2A shows, the
myeloperoxidase (MPO) activity and edema due to infiltrated
neutrophils after the topical application of tetradecanoylphorbol
acetate (TPA) were significantly attenuated when animals
received DTP1 and DTP5, but not after DTP2 (indomethacin
was used as the control). In addition, TNF-a production by whole958 Chemistry & Biology 21, 955–966, August 14, 2014 ª2014 Elsevier Ltd All rights reservedblood cells obtained from animals treated
orally withDTP1 andDTP5 (notwithDTP2)
was decreased after LPS challenge (Fig-
ure 2B). The anti-inflammatory activity
was also evaluated using the D-galactos-
amine (D-GalN)-sensitized LPS-depen-dent toxicity. As Figure 2C shows, only DTP1 and DTP5 exerted
a significant protection against the lethality induced by LPS/
D-GalN, both in LXRab+/+ and LXRab/ mice (p < 0.001 versus
the treatment with DTP1 or DTP5 in both cases). In agreement
with this, a dose-dependent inhibition of plasma TNF-a levels
(1 hr after LPS) was observed when animals were injected intra-
peritoneally (i.p.) with DTPs and 30 min later were injected i.p.
with LPS (1 mg/kg; Figure 2D). Also, inhibition of MPO activity
was observed in vivo using bioluminescence recording after
DTP5 (30 mg/kg) i.p. injection followed 1 hr later by zymosan
(10 mg/kg) administration (Figure 2E).
DTPs Inhibit the IKK/NF-kB and MAPKs Activation in
Response to Different Proinflammatory Stimuli
DTP1, DTP3, and DTP5 activate LXRab, nuclear receptors that
counteract NF-kB-dependent responses (Traves et al., 2007).
Therefore, we designed a series of experiments to evaluate the
anti-inflammatory effects mediated by DTPs independently of
LXR activation. Figure 3A shows a potent inhibitory effect of
DTP5 on NOS-2 and COX-2 protein levels regardless of the
absence of LXRab. The dose-dependent effect of all DTPs on
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Figure 3. The Anti-inflammatory Activity of
DTPs in Macrophages Is Partially Indepen-
dent of LXRab Nuclear Receptors and Inde-
pendent of MyD88 Signaling
(A) The levels of NOS-2 and COX-2 at 18 hr of
treatment with LPS in the absence or presence of
DTP5, and the time course of IkBa changes were
determined in macrophages from LXRab+/+ and
LXRab/ mice. T1317 (5 mM) was used as control
for maximal activation of LXRab.
(B and C) The protein levels of NOS-2 and COX-2
(B), and the accumulation of NO<i>x</i> in the cul-
ture medium (C) were measured after challenge
with LPS (250 ng/ml), LTA (5 mg/ml), or polyI:C
(25 mg/ml) in cells pretreated with the vehicle or
DTP5 (10 mM).
(D and E) The time course of the mRNA levels of
<I>NOS-2</I> and <I>COX-2</I> (D), and the
mRNA levels of <i>IkBa</i> and <I>IL-6</I> at 4 hr
after challenge with the indicated stimuli (E) were
determined using q-PCR and normalized versus
the housekeeping gene <i>36B4</i>.
(F) The accumulation in the medium of CXCL-10
was measured in macrophages from WT or
MyD88-deficient mice stimulated with LPS or
polyI:C, as in (B), and expressed as a percentage
versus the corresponding valuewith LPS or polyI:C
alone (values were 14 and 10.6 ng/ml for WT and
MyD88-KO mice treated with LPS, and 19.2 and
15.9 ng/ml for WT and MyD88-KO mice treated
with polyI:C, respectively).
The blots show a representative experiment out of
four (A and B), and the mean ± SD (n = 3; C–F).
*p < 0.05, **p < 0.01 versus the corresponding
condition in absence of DTP (C, E, and F); *p < 0.05,
**p < 0.01 versus the condition with the vehicle and
#p < 0.05, ##p < 0.01 versus the corresponding
value without DTPs (D).
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+/+ and
LXRab/ macrophages reflected a significant inhibition by the
active DTPs (Figure S3A). The effect of DTP1 on the time course
of NOS-2 and COX-2 expression was evaluated using LXRab/
macrophages (Figure S3B). Furthermore, DTP5 impaired IkBa
degradation in LPS-treated cells, regardless the presence of
LXRs. Nevertheless, the pharmacological activation of LXR
with T1317 was not able to modify the IkBa degradation induced
by LPS (Figure 3A), which agrees with previous work (Castrillo
et al., 2003a). These results suggest that DTPs are also inter-
fering with early signaling events after LPS challenge, indepen-
dent of the LXRs activation. In addition to LPS, the response of
macrophages to the TLR3 ligand polyriboinosinic:polyribocyti-
dylic acid (polyI:C) and to the TLR2 ligand lipoteichoic acid
(LTA) was analyzed. As Figure 3B shows, LPS, polyI:C, and
LTA promoted the expression of NOS-2 and COX-2, an effectChemistry & Biology 21, 955–966, August 14, 2014that was attenuated in the presence of
DTP5. Moreover, the accumulation of
NOx in the culture medium induced by
these stimuli was also inhibited by DTP5
(Figure 3C). The time course of NOS-2
and COX-2 mRNA levels after LPS chal-
lenge showed an inhibitory effect byDTP1 andDTP5 (Figure 3D). Figure 3E shows the inhibitory effect
of DTP5 on the IkBa and IL-6mRNA levels after the activation of
TLR2, TLR3, and TLR4 with LTA, polyI:C, and LPS, respectively.
When MyD88-deficient mice were used, DTP1 and DTP5 in-
hibited the accumulation of CXCL-10 in LPS and polyI:C-stimu-
lated macrophages, regardless of the presence of MyD88
(Figure 3F). This suggests, together with the data from LTA treat-
ment, that DTPs are effective in both the MyD88- and TRIF-
dependent pathways.
Our data point to a possible effect of the DTPs at early
signaling events after proinflammatory challenge; thus, to study
the effect of these DTPs on IKK activation, we immunoprecipi-
tated this enzyme from cells pretreated with the indicated
DTPs (30 min) and then with LPS (10 min). The IKK activity was
determined in vitro using purified IkBa as the substrate and
measuring the phospho-Ser32-IkBa levels using specificª2014 Elsevier Ltd All rights reserved 959
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Figure 4. Inhibition of NF-kB and MAPKs
Pathways by Acanthoic Acid-Related DTPs
(A) Macrophages were pretreated for 30 min with
10 mM of the indicated DTPs and then activated for
10 min with 250 ng/ml of LPS. The activity of IKK
was assayed after immunoprecipitation (IP) of the
enzyme and using purified IkBa as substrate and
an Ab against p-Ser32-IkBa.
(B) The levels of p-Ser32-IkBa were determined
using immunoblot in cells treated with 10 mM
MG132 to inhibit proteasomal degradation.
(C and D) The direct effects of DTPs on purified
IKKb activity were determined after addition of
10 mM DTPs to the assay (C) and by homogeneous
time-resolved fluorescence (HTRF) assays, using
biotinylated IkBa (28–40 amino acids) as substrate
and inhibition by staurosporine as a control (D).
(E–H) The effect of DTP5 on the LPS-activation of
NF-kBwas determined using EMSAs (E). The effect
of DTP5 on the phosphorylation levels of IKK, IkBa,
and IkBb (F); ERK, p38, and JNK MAPKs (G); and
the p38 upstream kinase MKK3/6 (H) were deter-
mined using immunoblot.
Results show a representative experiment out of
three.
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cells pretreated with DTP1, DTP3 and DTP5. Figure 4B shows
the effect of DTP5 on the in vivo phosphorylation of IkBa in
Ser32, analyzed after proteasome inhibitionwithMG132, inmac-
rophages challenged with LPS or polyI:C. Furthermore, the
in vitro addition of DTPs to immunoprecipitated IKK from LPS-
treated cells did not affect the activity of this enzyme (Figure 4C).
The direct effects of the DTPs on IKK were evaluated using re-
combinant IKKb (that is constitutively active) and adding the
DTPs to an in vitro homogeneous time-resolved fluorescence
(HTRF) assay. As Figure 4D shows, the activity remained unaf-
fected by the DTPs when assayed up to 100 mM. As expected,
treatment with staurosporine, which was used as a positive con-
trol, inhibited IKK. The activation and translocation to the nucleus
of NF-kB, evaluated using electrophoretic mobility shift assays
(EMSAs), were significantly impaired when cells were incubated
with DTP5 (Figure 4E) and DTP1 (not shown), which agrees with
an LXR-independent effect. Figure 4F shows the time-depen-
dent changes in IKK phosphorylation, which were less in the
presence of DTP5, and the levels of IkBa and IkBb, which
showed a delayed degradation (for IkBb), and a more rapid
resynthesis (for IkBa). Under the same conditions, the LPS-960 Chemistry & Biology 21, 955–966, August 14, 2014 ª2014 Elsevier Ltd All rights reservedependent activation of the MAPKs ERK
and p38 was inhibited by DTP5, whereas
c-Jun N-terminal kinase (JNK) activation
was less affected (Figure 4G). Consistent
with these data, the phosphorylation of
dual-specificity mitogen-activated protein
kinase kinase 3 and 6 (MKK3/6), an up-
stream kinase of p38 (Risco et al., 2012),
was reduced in LPS-activated macro-
phages incubated with DTP5 (Figure 4H).
In addition, activation with polyI:C or
LTA of DTP5-pretreated macrophagesshowed a decreased IKK and p38 phosphorylation, but without
noticeable effects on ERK and JNK phosphorylation (Figure 5).
Taken together, these data pointed to early steps of IKK/
NF-kB andMAPKs signaling as themain targets in the LXR-inde-
pendent mechanism of action of DTP5.
DTP1, DTP3, and DTP5 Activate the PI3K/Akt Pathway
Previous reports indicate that the PI3K/Akt pathway plays a
negative role on NF-kB activation in macrophages (Dı´az-Guerra
et al., 1999; Fukao and Koyasu, 2003). In view of our results pre-
sented here, we reasoned that this pathwaywas one likely candi-
date to mediate the effects of the DTPs. DTP1, DTP3, and DTP5,
but not DTP2 and DTP4, promote the phosphorylation of Akt in
Ser473, without altering Akt protein levels (Figure 6A). The time
course of Akt phosphorylation by DTP5 is shown (Figure 6A,
right). This S473-Akt phosphorylation was visualized using a
confocal microscopy (Figure 6B), and the activation was also
observed upon challengewith polyI:C or LTA (Figure 6C). In addi-
tion to Ser473-Akt, Thr308-Akt was also phosphorylated in
response to DTP5 (Figure 6D). Furthermore, Akt was phosphor-
ylated in vivo after the administration of DTP1, DTP3, and DTP5,
but not with DTP2 and DTP4, in the TPA-induced ear edemad
Figure 5. Effect of DTP5 on IKK and MAPKs Activation in Macro-
phages Treated with polyI:C or LTA.
Cells were treated as described in Figure 3B with polyI:C (25 mg/ml) or LTA
(5 mg/ml), and extracts were prepared at the indicated times to determine
IKK and MAPKs phosphorylation levels. Results show a representative blot
out of four.
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(Figure S4B). Akt phosphorylation was dependent on PI3K
activation, as deduced by the determination of the PIP2 phos-
phorylation in cell extracts immunoprecipitated with anti-p85
(Figure 6E). A positive control (50 nM insulin treatment) was
included in the assay. Inhibition of PI3K with the broad inhibitor
LY294002 suppressed Akt phosphorylation and PI3K activity.
The effects of DTP5 on the inhibition of IKK, ERK, and p38 phos-
phorylation were attenuated when cells were treated with
LY294002 (Figure 6F). Consistent results were obtained using
LXRab/ macrophages where the inhibition of Akt suppressed
the effect of DTP5 decreasing NOS-2, COX-2, CXCL-1, and
CXCL-10 levels (Figure S3C). Using NIH 3T3 cells transiently ex-
pressing a p110 wild-type (WT) or p110 kinase-deficient (KD)
construct (Dı´az-Guerra et al., 1999), the absence of p110 activity
significantly decreased the DTP5-dependent phosphorylation of
Akt (Figure 6G). LY294002 has been successfully used to clarify
the physiological roles of PI3K; however, this compound is an
effective inhibitor of all PI3K isoforms and of casein kinase 2
(Searl and Silinsky, 2005). To gain insights into the specificity
of PI3K activation by DTPs, we used highly selective p110 isoen-
zyme inhibitors. The inhibition of p110g and p110d, and to a
lesser extent of p110b, resulted in the suppression of the phos-
phorylation of Akt in response to DTP1 (Figure 7A). Indeed, the
effect of DTP1 on IKK inhibition was reverted in the presence
of the p110d inhibitor, and more efficiently after dual inhibition
of p110d and p110g (Figure 7B). Because pharmacological
studies always face the problem of specificity, we performed
gene silencing with small interfering RNAs (siRNAs) specific for
PI3K catalytic subunits (p110a, p110b, p110d, and p110g). The
qPCR revealed significant knockdown of p110a, p110b,
p110g, and p110d expression using selective siRNAs (Fig-
ure S4C). In accordance with the pharmacological inhibitors,
the levels of p-Akt increased by the action of DTP1when the cells
expressed p110g or p110d (Figure S4D). Moreover, the ability of
DTPs to directly activate PI3K was assayed after in vitro expres-
sion/translation of p110a (as a negative control) and p110d, and
as Figure S4E shows, DTP5 enhanced the phosphorylation of
PIP2 only in the presence of p110d. In addition, using confocal
microscopy and GFP-tagged Akt pleckstrin homology domainChemistry & Biology 21, 95(GFP-AktPH) as a molecular propidium iodide (PI)-sensor, we
show that DTP1 promoted an increase in the fluorescence at
the time that the probe aggregated in the perimembrane domain,
suggesting a rapid and direct action of this DTP on PI3K activity
(Figure S4F).
DISCUSSION
Few studies have evaluated and molecularly characterized the
anti-inflammatory effects of acanthoic acid, first isolated from
the root bark of Acanthopanax koreanum Nakai, which has
been used in traditional Korean medicine for the treatment of
rheumatism and other chronic inflammatory diseases (Kang
et al., 1996; Kim et al., 2004; Park et al., 2004), and now identified
in other plants, including a bush native to California, Coleonema
puchellum. Previous work using a series of synthetic analogs of
this molecule identified the main structural motifs essential for
their anti-inflammatory properties (Kang et al., 1996; Kim et al.,
2004). As we described previously, some of these DTPs are
potent activators of LXRab, which might explain in part their
anti-inflammatory effects (Traves et al., 2007); however, these
DTPs retain part of their anti-inflammatory activity when assayed
in LXRab/ mice. We found that the chemical modifications
introduced in the DTPs, mainly positional modifications of the
R-group at C4 of ring A, render molecules that have different
quantitative effects on the expression of typical proinflammatory
genes. Most of the studies in this report have been performed
using DTP1 and DTP5 because these molecules exhibited
greater effects in models of inflammation (effects persistent
even in the absence of LXRab) that were chemically more stable
than the other potent derivative, DTP3.
Our data show that DTPs negatively regulate inflammatory re-
sponses triggered by different TLRs, both in vitro and in vivo,
decreasing the expression of cytokines, chemokines, and proin-
flammatory mediators. These DTPs significantly inhibit the IKK/
NF-kB pathway and the ERK/p38 MAPKs activated in response
to LPS. These results are consistent with previous studies in
which DTPs with kaurene structure, in addition to the NF-kB
pathway, also inhibited these MAPKs (Castrillo et al., 2001a).
LPS activates TLR4, which is the only receptor able to signal
through both MyD88-dependent and TRIF-dependent pathways
(Aksoy et al., 2005; Gordon, 2007; Jin and Lee, 2008; O’Neill and
Bowie, 2007). Similar results were obtained when macrophages
were activated with TLR2 (MyD88-dependent) or TLR3 (TRIF-
dependent) ligands. Interestingly, the absence of MyD88 (using
CXCL-10 as the expression target) did not affect the inhibitory
actions of DTPs upon challenge with LPS or polyI:C. All together,
these data suggest the presence of a shared target for DTPs,
common to the different signaling pathways analyzed but inde-
pendent of MyD88 or TRIF. Moreover, these inhibitory effects
persisted when the compounds were assayed in macrophages
from LXRab/ mice, pointing to an upstream nuclear recep-
tor-independent mechanism. In this regard, the EMSAs demon-
strated that DTPs reduced NF-kB translocation to the nucleus in
addition to the transrepression effects described for the LXRs
inhibition of NF-kB activity (Castrillo and Tontonoz, 2004; Traves
et al., 2007). In a previous work, the action of these DTPs was as-
sayed in LXRabWT and KOmice after 24–48 hr of treatment with
the DTPs (Traves et al., 2007); however, because LXR-deficient5–966, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 961
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Figure 6. DTP1, DTP3, and DTP5 Activate
the PI3K/Akt Pathway in Peritoneal Macro-
phages
(A) Cells were treated with the indicated DTPs
(10 mM) for 30 min, and the levels of p-Ser473-Akt
were determined (left). The time course of Ser473-
Akt phosphorylation inducedbyDTP5wasanalyzed
(right).
(B) Visualization of p-Ser473-Akt (green) using a
confocalmicroscopy.Nucleiwere stainedwithDAPI
(blue).
(C) Macrophages treated with the vehicle or DTP5
for 30 min were activated as in Figure 3B with LPS,
polyI:C, or LTA (30 min), and the levels of p-Ser473-
Akt were determined.
(D) The p-Thr308-Akt and p-Ser473-Akt were
determined in cells incubated with LPS (250 ng/ml),
DTP5 (10mM), andLY294002 (10mM); insulin (50nM)
was used as positive control. Cells incubated with
DTP5 (10mM), LY294002 (10mM), and insulin (50nM)
for the indicated times were homogenized and
immunoprecipitated with anti-p85 Ab.
(E) PIP2-kinase activity was determined in vitro and
visualized using thin-layer chromatography. Sam-
ples of the extractswere used to determine p85 and
p-Ser473-Akt/Akt levels.
(F) Effect of LY294002 on the time course of Akt,
IKK, and MAPKs phosphorylation in macrophages
treated with DTP5 and LPS.
(G) NIH 3T3 cells were transfected with a p110
kinase-deficient (KD) or wild-type plasmids, and
the effect on p-Ser473-Akt levels was determined
after incubation with LY294002 and DTP5. Insulin
was used as a positive control.
Results show a representative experiment out of
three.
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alterations have been described (A-Gonzalez et al., 2013), we
preferred to use WT animals and to evaluate the effects of
DTPs for the short times analyzed in the present report. Studies
in vivo with DTP1 and DTP5 showed a significant anti-inflamma-
tory action in all the models assayed. The synthesis of TNF-a by
whole blood collected from animals treated orally with these
DTPs was inhibited; systemic i.p. administration significantly de-
layed the rate of animal death in amodel of LPS/D-GalN-induced
hepatotoxicity (even in the absence of LXRab), decreased the
LPS-induced TNF-a plasma levels, and reduced the zymosan-
induced peritoneal inflammation; and finally, the development
of TPA-induced edema was also prevented to levels similar to
those elicited by indomethacin.
When the inhibition of the NF-kB early signaling was investi-
gated, we were unable to observe a direct effect of the DTPs on
the activity of the IKK complex despite IKKb phosphorylation be-
ing abrogated. Various reports show that PI3K contributes to the
fine-tuning of the initial phases of the innate immune response to
diverse microbial pathogens (Fukao and Koyasu, 2003; Hazeki
et al., 2007; Ruse and Knaus, 2006). In dendritic cells andmacro-962 Chemistry & Biology 21, 955–966, August 14, 2014 ª2014 Elsevier Ltd All rights reservedphages, the activation of PI3K/Akt was
found to limit LPS-induced production of
cytokines and chemokines and the ex-
pression of NOS-2 through both MyD88-dependent and -independent pathways (Aksoy et al., 2005). In
this study, we have shown that DTP1, DTP3, and DTP5 induce
a persistent Akt phosphorylation in vivo (ear edema and liver)
and ex vivo (macrophages) at the two major sites, Thr308 and
Ser473. We confirmed that this Akt activation was dependent
on PI3K activity as far as it was suppressed by PI3K inhibitors.
Furthermore, the phosphorylation of Akt in Ser473 was blocked
by the expression of a kinase-deficient isoform of p110. In the
same way, the involvement of the DTP-dependent activation of
PI3K/Akt in the negative regulation of LPS-induced IKK, p38,
and ERK phosphorylation was confirmed by the suppression of
the DTPs effects after full PI3K inhibition (LY294002) or using se-
lective p110g/d inhibitors and siRNAs. Taken together, these data
contribute to a better understanding of themechanisms of action
of these DTPs in innate immunity. Finally, the dual action of DTP1,
DTP3, and DTP5 on the PI3K/Akt/MAPK/NF-kB axis, on the one
hand, and the selective activation of LXR, on the other, offers
the possibility of modifying key cellular responses involved in
many physiopathological processes in which macrophages play
an active role in the onset of the disease, including inflammatory
diseases, diabetes, and perhaps cancer.
AB
Figure 7. DTPs Induce p110g/d-Mediated
Activation of Akt in Peritoneal Macrophages
(A) Peritoneal macrophages were treated for 1 hr
with increasing concentrations of highly selective
inhibitors for the different p110 isoforms of the
PI3K complex and then treated with DTP1 (10 mM;
30 min). The levels of p-Ser473-Akt were deter-
mined using immunoblot and expressed as a
percentage versus the vehicle condition.
(B) Cells were incubated with p110g (5 mM) and
p110d (1 mM) inhibitors for 60 min and then stim-
ulated with DTP1 (10 mM; 30 min) and/or LPS
(250 ng/ml; 30 min), as indicated. The effect of
DTP1 on the phosphorylation levels of IKK after
p110d or after dual inhibition of p110g/d was
determined using western blot. The band intensity
ratio pIKK/IKK was expressed as a percentage
versus the LPS condition in the absence of in-
hibitors and DTP. The relative inhibitory effect of
DTP1 was calculated for each condition.
Results show one representative blot out of
three (A and B) and the mean ± SD (n = 3) of the
indicated band ratios (B, left). *p < 0.05; **p < 0.01
versus the corresponding condition in absence
of DTP1.
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Our results demonstrate that these DTPs negatively regulate
IKK/NF-kBandMAPKs (p38andERK)pathwaysby increasing
p110g/d activity and, consequently, Akt phosphorylation. The
ability of our compounds to selectively activate some iso-
forms of PI3K opens new prospects in the clinical develop-
ment of anti-inflammatory molecules and points to the use
of these acanthoic acid-related DTPs as anti-inflammatory
and possibly anticancer drugs with potential therapeutic
activity in inflammatory pathologies targeting simultaneously
the PI3K/Akt, LXRab, and NF-kB pathways.
EXPERIMENTAL PROCEDURES
Chemicals
Reagents were obtained from Sigma-Aldrich, Roche, Amersham-GE Health-
care, Merck, Bio-Rad, R&D Systems, and Promega. DTPs were synthesized
by Prof. E. Theodorakis (University of California, San Diego) and were dis-
solved in DMSO before being used in cell culture (Ling et al., 2000, 2001).Chemistry & Biology 21, 955–966, August 14, 2014Antibodies were from Santa Cruz Biotech, Cell
Signaling, Abcam, PeproTech, Sigma-Aldrich, Milli-
pore, and R&D Systems. Specific TLRs ligands
(LPS from Escherichia coli, LTA, and polyI:C) were
from Invivogen. Inhibitors LY294002, MG-132,
PI3Ka inhibitor VIII, PI3Kb inhibitor VI, and PI3Kg
inhibitor were purchased from Calbiochem. The
PI3Kd (CAL-101) inhibitor was from Selleck Chemi-
cals. Electrophoresis and protein reagents were
from Bio-Rad. Tissue culture dishes were from
Falcon, and culture media and fetal calf serum
(FCS) were from GIBCO (Life Technologies) and
Sigma.
Animals
Male mice were housed and bred in our path-
ogen-free facility and were maintained on stan-dard chow under pathogen-free conditions. BALB/c were from Charles River
Laboratories. LXRab+/+ and LXRab/ mice (mixed Sv129/C57BL/6 back-
ground) were obtained as previously described (Traves et al., 2007).
MyD88+/+ (WT) and MyD88/ (KO) were obtained from a collaboration
with Dr. T. Miethke (Institute for Medical Microbiology Immunology and
Hygiene, Technical University of Munich). The study was conducted following
the guidelines of the Spanish Animal Care and Use Committee, according to
the guidelines for ethical care of experimental animals of the European Union
(2010/63/EU).
Peritoneal Macrophage Isolation
Animals were used at ages 8–12 weeks, as indicated in the online Supple-
mental Information.
Cell Death Detection
Cells were collected and washed in cold PBS. After centrifugation for 5 min at
4C and 1,000 3 g, cells were resuspended in annexin V binding buffer
(10 mM HEPES; pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and labeled with
annexin V–FITC (BD/PharMingen) and/or propidium iodide (PI; 100 mg/ml)
for 15 min at room temperature (RT) in the dark, following a previous protocol
(Hortelano et al., 2003). Analysis was carried out using a FC 500 BD FACScan
flow cytometer.ª2014 Elsevier Ltd All rights reserved 963
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NO release was measured as the accumulation of nitrite and nitrate in the in-
cubation medium (phenol-red free). Nitrate was reduced to nitrite with nitrate
reductase and was determined spectrophotometrically with Griess reagent;
the absorbance at 548 nm was compared with a NaNO2 standard.
Cytokine and Chemokine Assays
Cytokines production by cultured macrophages and its accumulation in the in-
cubation medium were quantified using ELISA kits from PeproTech according
to the manufacturer’s instructions. Serum TNF-awas measured using Cytoset
ELISA kits (Biosource International). Levels of CXCL-1 and CXCL-10 were
measured using ELISA kits from R&D Systems according to the supplier’s
instructions.
Quantitative PCR
We used 1 mg of total RNA, extracted with TRI Reagent (Ambion, Life Technol-
ogies) according to the manufacturer’s instructions and processed as indi-
cated in the online Supplemental Information.
Preparation of Total Protein Cell Extracts
Cells were homogenized in a buffer containing 10 mM Tris-HCl (pH 7.5), 1 mM
MgCl2, 1 mM EGTA, 10% glycerol, 0.5% CHAPS, 1 mM b-mercaptoethanol,
0.1 mM phenylmethanesulfonylfluoride (PMSF), and a protease and phospha-
tase inhibitor cocktail (Sigma-Aldrich). The extracts were vortexed for 30min at
4C, and after centrifuging for 15 min at 13,000 3 g, the supernatants were
stored at 20C. Protein levels were determined using the Bio-Rad reagent.
Preparation of Cytosolic and Nuclear Extracts
Cells were collected into ice-cold PBS, resuspended in 200 ml of cytosolic
buffer (10 mM HEPES; pH 8, 1 mM EDTA, 1 mM EGTA, 10 mM KCl, and
0.5% Nonidet P-40) and left to swell on ice for 15 min. The tubes were gently
vortexed for 30 s, and the nuclei were collected using centrifugation at
13,000 3 g for 10 min (Castrillo et al., 2001a, 2003b). The supernatants were
stored at 20C (cytosolic extracts); the pellets were resuspended in 50 ml
of nuclear buffer (20 mM HEPES; pH 8; 0.4 M NaCl, 1 mM EDTA, 1 mM
EGTA, and 20% glycerol) and gently shaken for 30 min at 4C. Nuclear protein
extracts were obtained using centrifugation at 13,000 3 g for 10 min, and the
supernatants were transferred to a fresh tube and stored at 80C. Protein
content was assayed using the Bio-Rad protein reagent. All cell fractionation
steps were carried out at 4C. All buffers contained protease and phospha-
tase-inhibitor cocktail (Sigma-Aldrich) (Prieto et al., 2010).
Characterization of Proteins Using Immunoblot
Protein extractswere boiled in loadingbuffer (250mMTris-HCl; pH6.8, 2%SDS,
10% glycerol, 2% b-mercaptoethanol) and size separated using 10%–15%
SDS-PAGE gels, as indicated in the online Supplemental Information.
EMSAs
The sequence 50-TGCTAGGGGGATTTTCCCTCTCTCTGT-30, corresponding
to the consensus NF-kB binding site (nucleotides978 to952) of the murine
NOS-2 promoter (Castrillo et al., 2001a), was used and assayed as indicated in
the online Supplemental Information.
Measurement of IKKb Activity
Cells (107) were homogenized in cytosolic buffer and centrifuged at 13,0003 g
for 15 min. The supernatant (1 ml) was precleared, and IKKb was immunopre-
cipitatedwith 1 mg of anti-IKKb (Castrillo et al., 2001b). After the immunoprecip-
itate was extensively washed with cytosolic buffer, the pellet was resuspended
and assayed as indicated in the online Supplemental Information.
Measurement of PI3K Activity
PI3Kactivitywasmeasured in the anti-p85Ab immunoprecipitates using in vitro
phosphorylation of PIP2 as previously described (Dı´az-Guerra et al., 1999).
In Vitro Translation of p110a and p110d and Measurement of PI3K
Activity
The vectors encoding p110a, p110b, and p110d and the regulatory subunit
p85a were kindly provided by Dr. Julian Downward (Cancer UK, London),964 Chemistry & Biology 21, 955–966, August 14, 2014 ª2014 ElseviDr. Bart Vanhaesebroeck (QueenMary University, London) and Dr. Ana C. Car-
rera (CNB, Madrid). The p110a and p110d were subcloned in a PSG5 vector
(Agilent Technologies) and transcribed and translated in vitro using the Mega-
script T7 kit for transcription (Life Technologies) and the TNTQuick Translation
System (Promega) for translation and incorporating the transcribed p85a in the
translation reaction. The PI3K complexes were recovered after immunoprecip-
itation (IP) with anti-p85 Ab and the kinase activity wasmeasured as previously
described (Dı´az-Guerra et al., 1999).
Confocal Microscopy
Peritoneal macrophages (1 3 105) were grown on coverslips and incubated
with the indicated stimuli. After the covers were washed with PBS, the cells
were fixed with paraformaldehyde (4%; pH 7.2) for 15 min at RT and washed
again. The macrophages were permeabilized with cold methanol for 10 min at
RT. After incubation with anti-phospho-S473Akt (1:500) overnight at 4C, the
cells were washed with PBS, followed by incubation with anti-rabbit second-
ary Ab (Alexa-Fluor 488, 1:500) for 2 hr at RT. Nuclei were revealed by staining
with DAPI (1:3,000). Coverslips were mounted in Prolong Gold antifade re-
agent (Molecular Probes) and analyzed using an Espectral Leica TCS SP5
confocal microscope. Fluorescence intensity measurements were performed
using Image J software (NIH).
Transient Transfections
NIH 3T3 cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) containing antibiotics and 10% FCS. Before experiments were con-
ducted, the medium was challenged to 1% FCS. Transient transfections
were performed using FuGene HD transfection reagent (Roche), with a
FuGene:DNA ratio of 8:2 and following the indications of the manufacturer
(Roche). Transfection experiments were performed using vectors encoding
p110a wild-type (p110WT) and p110a kinase deficient (p110KD) (Dı´az-Guerra
et al., 1999). Phosphorylation of Akt was analyzed using immunoblot as a
marker of PI3K activity. In addition to this, a GFP-tagged-Akt pleckstrin homol-
ogy domain (GFP-AktPH) vector kindly provided by Dr. O.Weiner (University of
California, San Francisco) was used as a molecular sensor of PI3K activation
upon transfection in NIH 3T3 cells, following a previously described protocol
(Servant et al., 2000; Toettcher et al., 2011).
Gene Silencing with siRNAs
Peritoneal macrophages were transfected with Pik3ca, Pik3cb, Pik3cg,
Pik3cd, and nontargeting siRNAs (Thermo Scientific Dharmacon), using Lipo-
fectamine 2,000 transfection reagent (Invitrogen) and following the manufac-
turer’s instructions. After 48 hr, the medium was changed to RPMI medium
1,640 with 2% FCS, and the cells were stimulated for the indicated time
periods for protein or RNA expression analysis.
LPS-Induced D-GalN-Dependent Lethality Studies
An endotoxic shock was induced in male LXRab+/+ and LXRab/ mice ages
8–10 weeks old. The lethal injury was produced by i.p. injection of LPS
(10 mg/kg) in combination with D-GalN (800 mg/kg). The DTPs (30 mg/kg)
were administered i.p. in 0.5 ml solutol 1 hr prior to challenge with D-GalN/
LPS. Solutol was given to the control animals. The lethality wasmonitored until
25 hr after the administration of LPS/D-GalN.
12-O-Tetradecanoylphorbol Acetate-Induced Mouse Ear Edema
and Myeloperoxidase Activity Assay
A solution of 2 mg TPA dissolved in 20 ml DMSOwas applied to both surfaces of
the right ear of each mouse. The left ear (control) received the vehicle (DMSO).
The DTPs were administered topically (500 ng per ear in 20 ml DMSO) simulta-
neously with the TPA application. The reference drug, indomethacin, was
administered at the same doses. After 4 hr, the animals were killed by cervical
dislocation and a 6 mm diameter disc from each ear was removed using a
metal punch and weighed. Ear edema was calculated by subtracting the
weight of the left ear (vehicle) from the right ear (treatment). Ear sections
were homogenized in 750 ml of saline. After centrifugation at 10,000 3 g for
15 min at 4C, MPO activity was measured in supernatants, as described
before (Navarro et al., 1997). In addition to this, ear samples obtained at
30 min after DTP + TPA administration were homogenized and processed
using western blot to evaluate the phosphorylation of Akt.er Ltd All rights reserved
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C57BL/6 mice were starved overnight and orally administrated 25 mg/kg of
DTP1 and DTP5 prepared in 40% Solutol HS15 (BASF). After 90 min, whole
blood was collected, as indicated in the online Supplemental Information.
Bioluminescence Imaging of Myeloperoxidase Activity In Vivo
MPO activity was measured in the whole animal, as described previously
(Gross et al., 2009). Briefly, BALB/c mice were pretreated with the DTP5
(30 mg/kg), and after 1 hr zymosan (10 mg/kg) was administered by i.p. injec-
tion. At the times indicated, luminol (5mg in 200 ml; Sigma) was injected i.p. and
the bioluminescence was recorded in an IVIS Lumina (Caliper Life Sciences).
Microarray Analysis
RNA samples were labeled and hybridized in Agilent 4x44K one-color micro-
arrays following themanufacturer’s protocol and after two independent exper-
iments. The slides were scanned and images were converted to raw signal txt
files using Feature Extraction software (Agilent). Data preprocessing and
normalization were performed using Codelink and Limma and Bioconductor
packages (Gentleman et al., 2004). Differential expression was analyzed using
the Limma paired t test (Smyth, 2005), as implemented in Pomelo II (Morrissey
and Diaz-Uriarte, 2009). Gene-set-enrichment analysis was done using the
FatiScan method in Babelomics v.3 (Al-Shahrour et al., 2006).
Statistical Analysis
Unlessotherwise stated,data are expressedasmean±standarddeviation (SD).
To compare means between two independent samples, we used the Mann-
Whitney rank sum test. The results were considered significant at p < 0.05.
Data were analyzed using the SPSS for Windows statistical package v.21.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2014.06.005.
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